fincash logo SOLUTIONS

Fincash » Search » Dr Reddy's Laboratories Ltd

Dr Reddy s Laboratories Ltd

Updated on November 12, 2019

Stock/Share Code - DRREDDY

Dr Reddys Laboratories is a leading India-based pharmaceutical company headquartered and having its registered offi ce in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Ser...Read more

Below is the details of DRREDDY Dr Reddy s Laboratories Ltd

Market Cap₹42,484 Cr.
Current Price ₹2,730.8 as on 15 Nov 19
52 Week High / Low Price₹2,965.2 / ₹1,872.95
Face Value₹5
Stock P/E28.39
Book Value₹763.58
Dividend Yield0.78 %
ROCE11.86 %
ROE9.89 %
Sales Growth (3yrs)1.07 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Company has been maintaining a healthy dividend payout of 36.17%
Cons: Stock is trading at 3.35 times its book value The company has delivered a poor growth of 1.78% over past five years. Promoter holding is low: 26.76% Company has a low return on equity of 8.81% for last 3 years. Earnings include an other income of Rs.711.70 Cr.

Dr Reddy s Laboratories Ltd Price Chart

Dr Reddy s Laboratories Ltd Price Chart

Dr Reddy s Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹151.85 26.68 ₹108,066.05 Cr. 0.61 ₹1,387.48 Cr. 31.23 15.92 8374.36 11.19
2. Dr Reddy's Labs 28.39 ₹42,483.61 Cr. 0.78 ₹548.1 Cr. 66.65 -4.16 2508.70 11.86
3. Dr Reddy's Labs 19.76 ₹42,483.61 Cr. 0.78 ₹676.5 Cr. 42.09 3.26 3858.20 12.42
4. Piramal Enterp. ₹1,766.95 20.20 ₹40,383.41 Cr. 1.28 ₹450.89 Cr. 125.88 20.80 3506.25 9.42
5. Cipla ₹463.25 24.49 ₹38,074.18 Cr. 0.63 ₹478.19 Cr. 5.97 1.27 3989.02 10.94
6. Aurobindo Pharma ₹410.25 13.43 ₹35,197.33 Cr. 0.42 ₹635.83 Cr. 41.59 28.10 5444.60 18.45
7. Torrent Pharma. ₹14.25 36.90 ₹28,896.01 Cr. 1.00 ₹216 Cr. 32.52 8.01 2022.00 12.66
8. Biocon ₹257.25 34.11 ₹28,272 Cr. 0.21 ₹206.3 Cr. 72.35 30.44 1465.90 13.39

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Dr Reddy s Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
YOY Sales Growth %-9.93%4.85%-0.77%-3.42%-14.2%-1.77%5.6%25.26%16.71%8.27%6.13%-4.16%
Material Cost %25.26%22.53%30.54%27.41%29.35%25.64%30.08%26.25%26.84%28.5%32.74%30.47%
Employee Cost %18.28%18.78%15.77%21.56%20.07%18.89%18.59%17.84%19.12%17.27%18.52%19.91%
Operating Profit547641309148314536326575565687437431
OPM %21%25%13%7%14%21%13%22%21%25%17%17%
Other Income6489604940487335759373471
Profit before tax409529163-10140372196401433570296693
Tax %23%17%-36%28%28%20%10%18%20%30%32%21%
Net Profit313439223-7101297177329346399203548
EPS in Rs18.9126.4913.46-0.446.0717.9010.6519.8220.8624.0812.2233.06

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales Growth %-14.93%23.59%8.5%16.19%28.55%24.2%16.22%2.91%2.81%-5.56%-3.71%13.53%%
Material Cost %31.27%26.77%27.23%30.27%28.81%30.7%25.6%28.17%25.79%26.52%28.11%28.59%%
Manufacturing Cost %13.48%14.41%12.75%7.93%7.97%6.95%10.98%11.44%11.97%13.23%14.47%10.21%%
Employee Cost %10.34%9.46%10.87%13.36%12.85%13.6%14.6%14.89%16.45%18.55%19.69%18.18%%
Other Cost %27.98%28.93%24.51%25.73%27.41%25.03%20.44%21.62%25.72%23.48%23.52%21.37%%
Operating Profit5708501,1111,1901,5481,9862,7622,3912,0651,7711,3302,3002,119
OPM %17%20%25%23%23%24%28%24%20%18%14%22%20%
Other Income19110121211982142152223325566204238712
Profit before tax5847301,0851,0521,2591,7532,4542,0601,6771,5446971,7011,993
Tax %19%23%22%15%28%28%21%18%18%10%19%25%
Net Profit4755618468939121,2661,9331,6791,3741,3845671,2771,496
EPS in Rs27.6232.2548.2550.9851.5771.98113.5694.4880.5683.4834.1576.9590.22
Dividend Payout %13%19%22%21%26%20%16%20%25%24%59%26%

Compounded Sales Growth

  • 10 Years:: 9.83%
  • 5 Years:: 1.78%
  • 3 Years:: 1.07%
  • TTM:: 6.37%

Compounded Profit Growth

  • 10 Years:: 8.18%
  • 5 Years:: -8.83%
  • 3 Years:: -2.77%
  • TTM:: 65.69%

Return on Equity

  • 10 Years:: 13.13%
  • 5 Years:: 10.69%
  • 3 Years:: 8.81%
  • Last Year:: 9.89%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital848484858585858585838383
Equity Capital84.184.284.484.684.884.985.185.285.382.98383
Other Liabilities8771,2971,7861,7312,1702,1382,5362,7322,6642,7922,9572,659
Trade Payables613.37801194.3604.3847.3890.91013.7920.8971.81031.71287.61109.4
Total Liabilities6,1517,1968,2639,28710,42312,02214,53116,49217,82816,74817,35416,462
Fixed Assets9871,2111,3161,6911,8972,3872,7483,2494,4384,8424,7174,683
Gross Block1750.22157.32425.730253507.84208.74899.75815.675808675.49223.69774.1
Accumulated Depreciation762.8946.51110.1133416111821.72151.42566.23141.93833.34506.35091.4
Other Assets2,9863,8703,6474,5885,4316,8328,4008,8927,6978,2648,3257,445
Trade receivables897.71419.71060.51770.51943.52963.94561.54711.73889.54405.44203.83717.7
Cash Equivalents536.7384.436866.2849919.1665.1901.4202.166.8120.7113.2
Loans n Advances911.11331.21321.4776.5679.61026.61045.81000.41427.91395.61520.91186.4
Other Assets etc000911.7631.8396.1535.8554.9478.3586.4622.7412.4
Total Assets6,1517,1968,2639,28710,42312,02214,53116,49217,82816,74817,35416,462

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity5544861,2532461,4032899061,7862,7471,0161,5392,762
Profit from operations744.5992.11440.61328.52140.42438.43472.62655.92765.12192.81661.32976.3
Working Capital Changes-115.1-334.932.8-871-343.6-1773.8-2024.1-390.6379-854.151.324.6
Taxes paid-75.2-175.9-220.2-211.2-393.8-375.8-543-479.2-397.2-322.8-174-238.8
Cash from Investing Activity-1,520-744-1,117-609-425-524-874-2,031-1,9191,430-1,180-546
Fixed Assets Purchased-455.5-545.1-383-696.4-601.2-580.2-871.8-962.5-1083.7-985.1-798.2-652.8
Fixed Assets Sold2.82.918.72.90227.
Investments purchased-2348.9-1373.3-2695.8-1162.4-1370.4-1186.5-3581-3594.6-6532.5-4850.2-6062-7726.7
Investments sold1235.11634.92110.21260.211781262.63106.92609.66420.46952.75627.87478.6
Cash from Financing Activity46106-15261-19515228189-693-2,582-304-2,223
Proceeds from Shares1.
Proceeds from Borrowings324.2636.6730.52103.32205.53026.54439.527372576.20165.40
Repayment of Borrowings-196-439.7-749.1-1221.8-2116.4-2516.5-3523-2122-2786.9-613.6-0.1-1704.9
Interest Paid-9.8-18-12.1-4.2-62.9-87.5-82.8-68.7-75.1-63.6-70.6-64.5
Dividends Paid-73.7-73.8-123.2-814.1-221.6-270.8-297.9-357.4-407.3-335.3-399.2-400.2
Net Cash Flow-920-152-16-302783-8460-56135-13554-8

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %12%13%18%15%17%20%23%16%12%11%5%12%
Debtor Days9712586123105129171172138165164128
Inventory Turnover5.966.045.535.355.645.876.

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Dr Reddy s Laboratories Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.